Levomilnacipran

FDA Drug Profile

Drug Details

Generic Name
Levomilnacipran
Brand Names
N/A
Application Number
Sponsor
Hetero Labs Limited
NDC Codes
1
Dosage Forms
POWDER
Routes
N/A
Active Ingredients
LEVOMILNACIPRAN HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE FETZIMA ® is indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14 )]. Limitation of Use: FETZIMA is not approved for the management of fibromyalgia. The efficacy and safety of FETZIMA for the management of fibromyalgia have not been established. FETZIMA is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of Major Depressive Disorder (MDD) in adults ( 1 ). Limitation of Use : FETZIMA is not approved for the management of fibromyalgia. The efficacy and safety of FETZIMA for the management of fibromyalgia have not been established ( 1 ).